Plitidepsin is a cyclic depsipeptide antineoplastic agent that functions by targeting eukaryotic elongation factor 1A2 (eEF1A2), thereby inhibiting protein synthesis and inducing apoptosis in cancer cells.… Read more
Plitidepsin is a cyclic depsipeptide antineoplastic agent that functions by targeting eukaryotic elongation factor 1A2 (eEF1A2), thereby inhibiting protein synthesis and inducing apoptosis in cancer cells. Primarily utilized in research regarding relapsed or refractory multiple myeloma and various solid tumors, this compound has also been investigated for its potential antiviral properties. To support the rigorous analytical demands of pharmaceutical research and development, this category provides high-quality related compounds essential for the laboratory environment. These include reference standards such as specific impurities, metabolic metabolites, and stable isotope labelled compounds. Pharmaceutical laboratories rely on these specialized materials to perform accurate impurity profiling, validate analytical methods, and ensure consistent quality control, including high-performance liquid chromatography procedures, throughout the drug development and monitoring lifecycle.